Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implementing Genomic Testing for Lung Cancer Into Routine Clinical Practice - The Welsh Experience.

Clinical oncology (Royal College of Radiologists (Great Britain)) - 1 Nov 2022

Cox S, Powell C, Morgan S

Abstract excerpt

AIMS: Over the last decade there has been a rapid expansion of clinically actionable driver mutations in non-small cell lung cancer (NSCLC), with an unprecedented number of corresponding targeted therapies approved and funded for use in the clinic. Here we summarise the approach taken in Wales to embed a NSCLC biomarker testing pathway within the National Optimal Pathway for Lung Cancer. MATERIALS AND METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Lung Neoplasms

Share to Mutation

Source

Identifiers

PMID: 36088167
DOI: 10.1016/j.clon.2022.08.025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implementing Genomic Testing for Lung Cancer Into Routine Clinical Practice - The Welsh Experience.PMID 36088167Read ↗

Variations in Genomic Testing in Non-small Cell Lung Carcinoma: A Healthcare Professional Survey of Current Practices in the UK.Semantic proximity Read ↗

Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.Semantic proximity Read ↗

Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancerSemantic proximity Read ↗

Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA).Semantic proximity Read ↗

Genomic Landscape of NSCLC in the Republic of IrelandSemantic proximity Read ↗

Genomic landscape of stage 0-IA lung adenocarcinoma identified by on-site reflex targeted NGS.Semantic proximity Read ↗

Integration of rapid PCR testing as an adjunct to NGS in diagnostic pathology services within the UK: evidence from a case series of non-squamous, non-small cell lung cancer (NSCLC) patients with follow-up.Semantic proximity Read ↗

Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Reflex testing in non-small cell lung carcinoma using DNA- and RNA-based next-generation sequencing—a single-center experienceSemantic proximity Read ↗

Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns studySemantic proximity Read ↗

Optimising primary molecular profiling in non-small cell lung cancer.Semantic proximity Read ↗

Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.